Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipase family member M (LIPM) is one of the three putative epidermal lipases in mammals, characterized by a predicted lipase/abhydrolase domain structure and high expression in granular layer keratinocytes of the skin. While direct enzymatic activity and substrates in humans remain unverified, experimental evidence from mouse models indicates that LIPM is essential for the organization and maintenance of the skin's intercellular lipid matrix in the stratum corneum. Mice deficient in Lipm suffer fatal dehydration due to impaired skin barrier function, underscoring its pivotal biological role. LIPM’s precise function likely involves lipid hydrolysis or remodeling processes that support epidermal barrier formation, but its involvement as a human drug target remains unsupported and no pharmacological modulators or clinical biomarkers are currently established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipase family member M (LIPM).